상하이 푸단대학교 한단 캠퍼스 사진, 11월 14, 2018. [사진/IC]
상하이 푸단대학교 연구진이 4분 이내에 새로운 코로나바이러스 핵산을 검출할 수 있는 방법을 고안했다., 현재 국내에서 사용되는 방식보다 훨씬 빠르다..
연구팀은 새로운 접근 방식이 매우 민감하며 작은 크기를 사용한다고 말했습니다., 휴대용 장비.
In the polymerase chain reaction nucleic acid tests widely used in China to detect the virus that causes COVID-19, a fluorescent signal shows whether a sample is positive. To obtain a fluorescent signal of sufficient intensity, the nucleic acid in the sample needs to be extracted and amplified, and the whole testing process takes two hours or more.
하지만, in the new method, a transistor sensing chip with molecular electromechanical systems is able to complete rapid and ultrasensitive electromechanical detection of the virus’ ribonucleic acid in unamplified samples, which saves time.
Wei Dacheng, a leading researcher on the team that devised the method, said they converted the chemical signals of the virus’ nucleic acid into electrical signals.
“The conducting channel of a transistor is a semiconductor,” 그는 말했다. “When the reaction takes place on the channel, on one hand, the transistor converts chemical signals into electrical signals, and on the other, it can amplify such signals.
“So when there is even a small number of nucleic acids interacting with the semiconductor, a colossal number of charge carriers will be generated in the transistor owing to the doping effect. As long as we can detect a change in the current, we can determine the existence of COVID-19 virus in the sample.”
A paper about the research, jointly conducted by Fudan’s department of macromolecular science, its State Key Laboratory of Molecular Engineering of Polymers and experts from other institutions, was published in the journal Nature Biomedical Engineering on Feb 7.
The team said transistors had previously been used to detect ions, biological molecules and free radicals, but it significantly improved the performance of the transistor sensor to meet the requirements of high-sensitivity novel coronavirus detection.
“Our team used to use the transistor for the detection of free radicals, but the concentration of SARS-CoV-2 nucleic acids is lower than that by around 10 orders of magnitude,” Wei said. He said that the research is still at the laboratory phase and requires further clinical validation to ensure its stable performance in different real-world environments before it can be put into clinical application.
원천: 차이나 데일리
